Smiths Group plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SMGZY research report →
Price Chart
About the company
Smiths Group plc is a global technology enterprise, providing innovative solutions across diverse sectors such as medical technology, security and defense, general industrial applications, energy, and space and aerospace. The company's operations are segmented into five key divisions. John Crane specializes in critical engineering components, including mechanical seals, their associated support systems, hydrodynamic bearings, various packing materials, power transmission couplings, and advanced filtration solutions.
- CEO
- Roland Henry Clyne Carter
- IPO
- 2010
- Employees
- 10,435
- HQ
- London, GL, GB
Get TickerSpark's AI analysis on SMGZY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.87B
- P/E
- 3.99
- Fwd P/E
- 29.20
- PEG
- 0.01
- P/S
- 3.52
- P/B
- 3.04
- EV/EBITDA
- 13.24
- Div Yield
- 1.93%
- Gross Margin
- 39.86%
- Op Margin
- 15.54%
- Net Margin
- 101.70%
- ROE
- 92.97%
- ROIC
- 4.75%
Latest fiscal year · YoY change
- Revenue
- $1.90B-34.9%
- Gross Profit
- $756.68M+84.6%
- Op Income
- $296.99M
- Net Income
- $1.93B+561.3%
- EPS
- $6.16+660.5%
- OCF Growth
- -48.2%
- FCF Growth
- -54.8%
- 52W High
- $38.21
- 52W Low
- $28.29
- 50D MA
- $35.97
- 200D MA
- $34.92
- Beta
- 0.73
- RSI (14)
- 31
- Avg Volume
- 43.55K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Smiths delivered resilient FY26 results with organic growth, margin expansion and strong cash flow, while repositioning the portfolio and guiding to about 4% organic growth and roughly 21% margin in FY27.· September 22, 2026
- FY26 organic revenue grew 1.2% to GBP 1.9 billion and headline operating profit rose 1.9% organically to GBP 399 million.
- Headline operating margin improved 20 bps to 20.6%, and headline EPS increased 6% to 86.8p; operating cash conversion was 96%.
- The company completed the sales of Interconnect and Detection, crystallizing GBP 3.3 billion of enterprise value, and launched a process to divest the John Crane U.S. legacy asbestos liability.
- FY27 guidance calls for around 4% organic revenue growth, about 21% headline operating margin, and operating cash conversion in the low 90s.
- Management said momentum, pricing, DRC, and portfolio reshaping should help Smiths reach its 5% to 7% medium-term organic growth target faster.
FY26 headline organic revenue growth was 1.2% to GBP 1.9 billion. Headline operating profit increased 1.9% organically to GBP 399 million, and headline operating margin was 20.6%, up 20 basis points. Headline EPS rose 6% to 86.8p, total group headline EPS rose 12% to 135.7p, and operating cash conversion was 96% with operating cash flow of GBP 384 million. The Board proposed a final dividend of 33.5p, taking the full-year dividend to 48.5p, up 5.4%. For FY27, the company guided to organic revenue growth of around 4%, headline operating profit margin of approximately 21%, and operating cash conversion in the low 90s range.
Roland Carter framed FY26 as a defining year of portfolio transformation, saying the company has become a more focused premium industrial engineering business after the Interconnect and Detection divestitures. He emphasized growth pillars in energy, data centers, housing and aerospace, and said Smiths is not relying on a broad market recovery but instead on self-help, pricing, innovation, execution and disciplined M&A. His tone was confident and constructive, but he repeatedly acknowledged a still-challenging external backdrop, especially in the Middle East and U.S. residential construction.
Julian Fagge highlighted resilient FY26 numbers: 1.2% organic revenue growth to GBP 1.9 billion, operating profit of GBP 399 million, 20.6% operating margin, 86.8p headline EPS, and 96% cash conversion. He said organic growth was supplemented by 2.6% from acquisitions, including DRC, and noted that operating cash flow was GBP 384 million. On capital allocation, he pointed to GBP 64 million of RD&E, GBP 39 million of CapEx, the GBP 165 million DRC acquisition, completion of the GBP 500 million buyback, and completion of the GBP 1 billion Interconnect buyback with GBP 1.5 billion for Detection still to execute. He also said the asbestos liability averages about GBP 20 million of annual net cash outflow and that removing it would increase free cash flow and available capital.
Analysts focused on the Middle East disruption, Thermal Solutions growth, working capital, the asbestos divestiture, M&A discipline, tariffs, margins, and order coverage. Management said the Middle East impact should remain similar in the first half of FY27, largely on aftermarket, with year-on-year improvement in the second half as the company laps the GBP 20 million hit. On Thermal Solutions, they said last year’s destocking and project phasing should be largely cycled, helped by DRC and a more growth-oriented Flex-Tek portfolio. They also said tariffs were a headwind in FY26 but should be relatively neutral in FY27, and that order books remain solid, including about 1x in John Crane and strong coverage in aerospace.
The call showed multiple sources of upside: pricing power, improving mix, margin progression toward the 21% to 23% target range, and a more focused portfolio after major divestitures. Management is also optimistic about DRC and data center exposure, energy-security-related demand, and a longer-term recovery opportunity in John Crane once Middle East disruption eases.
Near-term conditions remain tough, especially the Middle East disruption, which management expects to continue through at least the first half of FY27, and the U.S. residential construction market remains subdued. Flex-Tek still faces mix pressure and some exposed end markets, tariffs were a headwind in FY26, and the asbestos liability process introduces another execution step even though management sees it as balance-sheet positive.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 108.2%
- Shares Outstanding
- 271.56M
- Float Shares
- 293.86M
Congressional trading
Senate and House stock disclosures for SMGZY, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Held by 11 ETFs
Biggest fund positions in SMGZY by dollar value.
Our SMGZY coverage
Recent articles, reports, and earnings notes.
No research on SMGZY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SMGZY report →Smiths Group plc (SMGZY) Q1 2027 Sales/Trading Call Transcript
seekingalpha.com · Nov 18
Smiths Group plc (SMGZY) Shareholder/Analyst Call Transcript
seekingalpha.com · Nov 18
Smiths Group Q1 Earnings Call Highlights
marketbeat.com · Nov 18
Smiths Group sticks to annual forecasts as Middle East disruption hits revenue growth
reuters.com · Nov 18
Smiths Group (OTCMKTS:SMGZY) Shares Cross Above 200-Day Moving Average – Time to Sell?
defenseworld.net · Nov 10
Smiths Group (OTCMKTS:SMGZY) Share Price Breaks Below 50 Day Moving Average – What’s Next?
defenseworld.net · Oct 20
Canopy Growth's Smiths Falls Facility Becomes Canada's Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
businesswire.com · Oct 13
Smiths Group PLC (OTCMKTS:SMGZY) Stock Short Interest Climbs 176.4%
defenseworld.net · Oct 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.